共 50 条
- [1] SARS-CoV-2 vaccination for patients with inflammatory bowel disease reply LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (07): : S23 - S24
- [2] Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 987 - 988
- [3] Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (12): : 1074 - 1075
- [4] SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (01): : 77 - 80
- [5] SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 989 - 989
- [7] SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease JOURNAL OF CROHNS & COLITIS, 2021, 15 : S564 - S564
- [8] SARS-CoV-2 vaccination does not increase the risk for flares in Inflammatory Bowel Disease patients JOURNAL OF CROHNS & COLITIS, 2023, 17 : 690 - 690
- [9] Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease JOURNAL OF CROHNS & COLITIS, 2021, 15 (12): : 2142 - 2143
- [10] Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients JOURNAL OF CROHNS & COLITIS, 2022, 16 (09): : 1347 - 1353